New Robotic-assisted Surgery For Treatment Of Oral, Head And Neck Disorders
6/6/2018
SCRANTON, Pa. (June 6, 2018) -- Surgeons at Commonwealth Health Regional Hospital of Scranton are performing a new robotic-assisted surgery called Trans Oral Robotic Surgery (TORS). TORS is an advanced, minimally invasive technique that allows removal of benign and malignant tumors of the mouth and throat. TORS may improve the way head and neck cancer patients are treated by completely removing tumors while preserving speech, swallowing and other quality of life issues.
During TORS, surgeons use precision robotic arms and high resolution cameras that allow them to work with greater accuracy in small, difficult-to-reach areas. This improved access could mean an easier and faster recovery for patients with the possibility of fewer complications. Some of these benefits may include a shorter hospital stay, faster recovery time, less risk of damage to surrounding muscles and less risk of long-term problems with speech and swallowing. Depending on the extent of their cancer, some patients may be able to avoid radiation therapy and/or chemotherapy.
Otolaryngologist, Mark Frattali, M.D. will present a free seminar on robotic surgery for head and neck malignancy at 6 p.m. June 26 at Regional Hospital of Scranton’s McGowan Large Conference Room, 743 Jefferson Ave., across from the main entrance to the hospital.
Dr. Frattali, who is an independent medical staff member at Commonwealth Health Regional Hospital of Scranton and Moses Taylor Hospital, will discuss the benefits of robotic-assisted surgery for the treatment of oral, head and neck disorders. The event is open to the public and free of charge, though reservations are recommended and can be made by calling (570) 552-7496.
Back